ComplianceWire Releases Significant Upgrades

UL Solutions announces the 2022 Release 2 (2022R2) version of its best-in-class ComplianceWire^® platform. ComplianceWire is the premier cloud-based, validated learning, compliance and qualification management system for pharmaceutical and medical device developers and manufacturers.

“Thanks to ongoing input from customers around the globe, we continue to improve upon the ease of use, power and flexibility of the industry-leading ComplianceWire system. This ongoing improvement has enabled the system’s wide adoption and continued use throughout the life sciences industry,” said Mike Lawrence, senior digital product manager of the Product Lifecycle group at UL Solutions.

Updates to the system include:

• New “My Team” dashboards.
  • Provides functional managers with an “at a glance” view of the full team’s qualification and compliance status.
  • Users can drill down to see the status by sub-teams or individual team members.
• Improved group entity management and single-sign-on (SSO) capabilities.
  • Enables users to get training completes faster.
  • Reduces time managers need to spend in the system on compliance tasks.
• Enhanced reporting.
  • Customers can better respond to audits and utilize training metrics.
  • New “User History Report” provides visibility and traceability of user attribute changes.

“Our 2022R2 release continues to build on the life sciences DNA embedded in ComplianceWire and makes it the leader in the pharmaceutical and medical device industries,” Lawrence said.

Created from a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration (FDA), ComplianceWire is used to train the FDA’s inspectors. It is also utilized with state, local and tribal inspection partners. Globally, China’s National Medical Products Administration (China NMPA), the Food and Drugs Control Administration for the state of Gujarat in India (Gujarat FDCA), and the Saudi Food and Drug Administration (Saudi FDA) all use ComplianceWire as a training tool.

More than 600 customers and 3.6 million users in 153 countries count on ComplianceWire to deliver the training to help develop critical pharmaceutical and medical devices in accordance with regulatory requirements.. Currently, UL Solutions manages the ComplianceWire business unit to help further its mission of working for a safer world and promoting the development and manufacture of safer pharmaceuticals and medical devices globally.

“We are extremely proud of the role ComplianceWire plays in helping to enable the development and manufacture of safer pharmaceuticals and medical devices. This system is a logical extension of the testing, inspection and certification and Global Market Access services we provide our customers,” said Jim O’Keefe, senior director of UL Solutions Product Lifecycle Compliance Wire team. “With ComplianceWire, we help make sure these products are manufactured by properly qualified individuals, consistent with Good Manufacturing Practices (GMP) and global regulatory policy.”

Learn more about how ComplianceWire can help your business, and contact UL Solutions with any specific questions you may have.